全文获取类型
收费全文 | 2404582篇 |
免费 | 173468篇 |
国内免费 | 3983篇 |
专业分类
耳鼻咽喉 | 35088篇 |
儿科学 | 81158篇 |
妇产科学 | 68164篇 |
基础医学 | 346749篇 |
口腔科学 | 68114篇 |
临床医学 | 205891篇 |
内科学 | 473874篇 |
皮肤病学 | 52399篇 |
神经病学 | 188592篇 |
特种医学 | 93195篇 |
外国民族医学 | 975篇 |
外科学 | 364864篇 |
综合类 | 49696篇 |
现状与发展 | 1篇 |
一般理论 | 655篇 |
预防医学 | 185353篇 |
眼科学 | 55505篇 |
药学 | 181194篇 |
3篇 | |
中国医学 | 4876篇 |
肿瘤学 | 125687篇 |
出版年
2018年 | 26251篇 |
2017年 | 19409篇 |
2016年 | 21444篇 |
2015年 | 24324篇 |
2014年 | 33030篇 |
2013年 | 50532篇 |
2012年 | 70647篇 |
2011年 | 75295篇 |
2010年 | 44044篇 |
2009年 | 40863篇 |
2008年 | 70992篇 |
2007年 | 76605篇 |
2006年 | 76896篇 |
2005年 | 75011篇 |
2004年 | 72492篇 |
2003年 | 69919篇 |
2002年 | 68502篇 |
2001年 | 108571篇 |
2000年 | 112282篇 |
1999年 | 95369篇 |
1998年 | 26685篇 |
1997年 | 23883篇 |
1996年 | 24242篇 |
1995年 | 22941篇 |
1994年 | 21691篇 |
1993年 | 20084篇 |
1992年 | 75879篇 |
1991年 | 74406篇 |
1990年 | 72990篇 |
1989年 | 70109篇 |
1988年 | 65107篇 |
1987年 | 63927篇 |
1986年 | 60299篇 |
1985年 | 57787篇 |
1984年 | 43407篇 |
1983年 | 36995篇 |
1982年 | 21908篇 |
1981年 | 19647篇 |
1979年 | 40195篇 |
1978年 | 28118篇 |
1977年 | 24224篇 |
1976年 | 22835篇 |
1975年 | 24956篇 |
1974年 | 29338篇 |
1973年 | 28344篇 |
1972年 | 26632篇 |
1971年 | 24563篇 |
1970年 | 23037篇 |
1969年 | 21706篇 |
1968年 | 20244篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Four clinical trials of porcine islet transplantation have been reported, and there are verbal reports that clinical trials on much larger scales are continuing in centers in China and Russia. The four reported trials are briefly reviewed and, in the light of the present status of experimental islet xenotransplantation, consideration is given to whether such trials are currently justified. The Ethics Committee of the International Xenotransplantation Association has (1) emphasized the need for encouraging studies in non-human primates before clinical trials should be undertaken, (2) mandatory monitoring for the transfer of porcine microorganisms, and (3) careful regulation and oversight by recognized bodies. Other aspects of the topic, such as the need for informed consent, are briefly discussed. We conclude that, at the present time, more data documenting convincing efficacy, focused on clinically applicable immunosuppressive regimens, are needed to justify the initiation of closely monitored clinical trials. A clinical trial may then be justified even though the potential risk to the patients, and possibly for society, will not be zero. 相似文献
92.
93.
94.
95.
H Ishihara M Bjeljac D Straumann Y Kaku P Roth Y Yonekawa 《Minimally invasive neurosurgery》2006,49(3):168-172
OBJECTIVE: A safe entry zone to tegmental lesions was identified based on intraoperative electrophysiological findings, the compound muscle action potentials (CMAP) from the extraocular muscles, and anatomic considerations. This entry zone is bordered caudally by the intramesencephalic path of the trochlear, laterally by the spinothalamic tract, and rostrally by the caudal margin of the brachium of the superior colliculus. METHODS: Four intrinsic midbrain lesions were operated upon via the safe entry zone using the infratentorial paramedian supracerebellar approach. All lesions involved the tegmentum and included an anaplastic astrocytoma, a metastatic brain tumor, a radiation necrosis, and a cavernous angioma. CMAP were bilaterally monitored from the inferior recti (for oculomotor function) and superior oblique (for trochlear nerve function) muscles. RESULTS: In three of four cases, CMAP related to the oculomotor nerve were obtained upon stimulation at the cavity wall after removal of the tumor. Stimulation at the surface of the quadrigeminal plate, however, did not cause any CMAP response. Using this monitoring as an indicator, the lesions were totally removed. CONCLUSIONS: In the surgery of tegmental lesions, CMAP monitoring from extraocular muscles is particularly helpful to prevent damage to crucial neural structures during removal of intrinsic lesions, but less so to select the site of the medullary incision. The approach via the lateral part of the colliculi is considered to be a safe route to approach the tegmental lesions. 相似文献
96.
97.
98.
99.
A Sharma H L Goh N Asokananthan A Bakker G A Stewart H W Mitchell 《The European respiratory journal》2006,27(1):20-28
Mucosal trypsin, a protease-activated receptor (PAR) stimulant, may have an endogenous bronchoprotective role on airway smooth muscle. To test this possibility the effects of lumenal trypsin on airway tone in segments of pig bronchus were tested. Bronchial segments from pigs were mounted in an organ chamber containing Kreb's solution. Contractions were assessed from isovolumetric lumen pressure induced by acetylcholine (ACh) or carbachol added to the adventitia. Trypsin, added to the airway lumen (300 microg x mL(-1)), had no immediate effect on smooth muscle tone but suppressed ACh-induced contractions after 60 min, for at least 3 h. Synthetic activating peptides (AP) for PAR1, PAR2 or PAR3 were without effect, but PAR4 AP caused rapid, weak suppression of contractions. Lumenal thrombin was without effect and did not prevent the effects of trypsin. Effects of trypsin were reduced by N(omega)-nitro-L-arginine methyl ester but not indomethacin. Trypsin, thrombin and PAR4 AP released prostaglandin E2. Adventitially, trypsin, thrombin and PAR4 AP (but not PAR2 AP) relaxed carbachol-toned airways after <3 min. The findings of this study show that trypsin causes delayed and persistent bronchoprotection by interacting with airway cells accessible from the lumen. The signalling mechanism may involve nitric oxide synthase but not prostanoids or protease-activated receptors. 相似文献
100.
AIMS: To establish all-cause and cause-specific death rates, and risk factors for mortality in insulin-treated diabetic individuals living in the province of Canterbury, New Zealand. METHODS: Insulin-treated diabetic subjects (n = 995) on the Canterbury Diabetes Registry were followed up over 15 years and vital status determined. Death rates were standardized and hazard regression was used to model the effects of demographic covariates on relative survival time. RESULTS: There were 419 deaths in 11 226.3 person-years of follow-up with a standardized mortality ratio (SMR) of 2.0 (95% confidence interval (CI) 1.8-2.2). Relative mortality was greatest for the group aged 0-29 years (SMR 3.0 (95% CI 2.4-3.7)). After controlling for diabetes duration and gender, a 10-year increment in age of onset was associated with a 33% decrease in relative hazard (95% CI 29-36%), indicating that excess mortality due to diabetes declines with rising age of onset. After controlling for age of onset and gender, each 10-year increment in duration of diabetes is associated with a 26% decrease in relative hazard (95% CI 24-29%), indicating that with longer survival the mortality hazard approaches the general population hazard. Relative mortalities were increased for cardiovascular, renal and respiratory disease, but not malignancy. Relative mortality from acute metabolic complications was increased in the subgroup with age of onset of diabetes < 30 years and requiring insulin within 1 year of diagnosis. CONCLUSIONS: Mortality rates are high for insulin-treated diabetic individuals relative to the general population. 相似文献